• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

STUDIES OF DEDIFFERENTIATION MECHANISMS IN HEPATOCELLULAR CRCINOMA

Research Project

Project/Area Number 06670244
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Experimental pathology
Research InstitutionKURUME UNIVRSITY

Principal Investigator

KOJIRO Masamichi  Kurume University, School of Medicine, Professor, 医学部, 教授 (90080580)

Co-Investigator(Kenkyū-buntansha) IEMURA Akihiro  Kurume University, School of Medicine, Fellow, 医学部, 助手 (40212724)
YANO Hirohisa  Kurume University, School of Medicine, Instructor, 医学部, 講師 (40220206)
Project Period (FY) 1994 – 1995
KeywordsHepatocellular carcinoma / Dedifferentiation / Growth factor / Autocrine mechanism / Basic fibroblast growth factor / Fibroblast growth factor receptor / Apoptosis / Fas antigen
Research Abstract

1. Growth Stimulating Factors of Hepatocellular Carcinoma (HCC) Cells. We examined the effects of known growth factors on the proliferation of two clonally related HCC cell lines (HAK-1A & HAK-1B). HAK-1A is morphologically more differentiated and biologically less malignant than HAK-1B.The two HCC cell lines expressed the proteins and mRNAs of basic fibroblast growth factor (bFGF) and its receptor, FGFR.In vitro and in vivo experiments by using anti-bFGF neutralizing antibody and exogenous bFGF revealed that : (1) well-differentiated HCC cell line, HAK-1A,possessed a proliferation mechanism regulated by a paracrine mechanism, mediated by bFGF/FGFR ; (2) poorly differentiated HCC cell line, HAK-1B,possessed both autocrine and paracrine proliferatio mechanisms mediated by bFGF/FGFR ; and (3) bFGF/FGFR system also plays an important role in cell growth, but does not relate to angiogenesis in vivo. As to other growth factos and their receptors, the two cell lines expressed transforming growth factor (TGF) -alpha and its receptor, epidermal growth factor receptor (EGFR). Anti-EGFR neutralizing antibody showed growth suppressive effect on the cell lines, but anti-TGF-alpha neutralizing antibody showed no effect. This suggested involvement of the other EGFR ligands (EGF,heparin binding-EGF,amphiregulin, beta-cellulin etc.) in the HCC cell proliferation.
2. Growth Inhibition and Apoptosis Inducing Factors of HCC Cells. TGF-beta showed no significant effects on the two cell lines. As to the expression of Fas antigen, which is a apoptosis inducing protein, HAK-1B showed lower level of Fas antigen expression and resistance to anti-Fas-mediated apoptosis.
In conclusion, HCC cells may acquire more efficient cell proliferaton mechanisms (autocrine/paracrine) mediated by bFGF/FGFR in their dedifferentiation process. Also, loss of Fas system after clonal cell dedifferentiation is favorable for HCC cells to escape apoptosis.

  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] 矢野博久: "肝細胞癌細胞株におけるBcl-2蛋白及びFas抗原の発現について" 肝臓. 35巻(suppl). 78 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 小笠原幸子: "ヒト肝細胞癌株におけるbasic Fibroblast Growth FactorおよびそのReceptorの発現について" 肝臓. 36巻. 343 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 矢野博久: "蛋白質合成阻害剤(cycloheximide)存在下におけるFas抗体の肝細胞癌細胞株に対するアポトーシス誘導促進" 肝臓. 36巻(suppl). 344 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yano H.: "Enhancement of anti-Fas antigen-mediated apoptosis in human hepatocellular carcinoma cell lines in the presence of the protein synthesis inhibitor cycloheximide." International Hepatology Communications.3(suppl). 146 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogasawara S.: "Expression of basic fibroblast growth factorand its receptor in human hepatocellular carcinoma cell lines." International Hepatology Communications.3(suppl). 146 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogasawara S.: "Expressions of basic fibroblast growth factor and its receptors,and relationship to their proliferation of human hepatocellular." Hepatology.(in press). (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogasawara S.: "Expression of basic fibroblast growth factor and its receptor in human hepatocellular carcinoma cell lines." Internaitonal Hepatology Communication. vol.3, Suppl.s146 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yano H.: "Enhancement of anti-Fas antigen-mediated apoptosis in human hepatocellular carcinoma cell lines in the presence of the protein synthesis inhibitor cycloheximide." International Hepatology Communication. vol.3, Suppl.s146 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogasawara S.: "Expressions of basic fibroblast growth factor and its receptors, and their relationship to proliferaton of human hepatocellular carcinoma." Hepatology. (in press). (1996)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi